Man has always been in fierce wars against various diseases and their causes that limit his life, and while medical science has evolved until they were able to reduce the danger of external diseases such as bacteria and viruses, they have so far failed to face internal diseases, which are genes that cause some diseases such as Alzheimer’s, cancer and sickle cell anemia.
Medical efforts on these diseases for many years have been limited to treating the symptoms that result from them, because doctors lack the mechanisms that make them treat the main cause of the disease, at least it was the case until the company “Mammoth Bioscience” revealed its new technology called “Crispr” in a lecture given by the founder of Trefor Martin founder Participant and CEO of the company within the 2025 web summit, which concluded its activities in the Qatari capital recently.
Genetic therapy as a solution to incurable diseases
Human genes cause a group of different diseases, which are diseases that result from a specific gene in the human DNA composition of humans and sometimes due to the absence of a gene or a false presence. Although science discovered the reason behind many of these diseases, but was able to identify the genes that caused them, contemporary medicine did not have the appropriate tools for behavior based on this knowledge and the treatment of diseases permanently.
Here comes the role of the “Krisper” technology developed by “Mammouth”, according to what Trevor Martin said in his lecture, the “Krisper” technique simply works to address the genetic problems present in the DNA, and through this technique the main cause of the disease can be eliminated, whether by deleting the gene responsible for it or by adjusting it in a way that makes the disease uncomfortable.
While this technique appears future and far, the company has managed to provide the first treatment that is exploiting it, which is a treatment for sickle cell anemia caused by a genetic defect that makes red blood cells unable to carry oxygen appropriately.
The treatment that is already dependent on this technique was presented in the United States, and this means that he passed all the necessary tests and obtained all approvals, and the treatment has proven effective in solving the problem completely and also avoided it in some cases.
Mother to amend text documents
Trevor gave a simple explanation of the way the “Krisper” technology works, and in order to bring the technology mechanism closer to users, it is clear that the technology deals with the genetic composition and human acid in a manner similar to the dealing of text document modification applications with documents.
To clarify, the technology can search for a specific genetic composition in the human DNA, similar to what the search engine in text modification applications is doing. When you find this particular genetic composition, it can adjust it, either by deleting the amino acids caused by the disease, or adding new nuclear acids to treat the disease.
The “Mammoth” team was inspired by this technique from monitoring the bacteria after being injured by the viruses that adjust its DNA, the team found that the bacteria remove the genetic relay that the virus amended, in a step to protect itself, so the team extracted this mechanism from the bacteria and launched the name “CRISPR” on it, and one of the members of the company’s research team won the Nobel Prize for Science for its research in its research “Krisper” technology.
Border horizons
Trevor concluded his talk about “CRISPR” technique by clarifying that this technique is not newly -covenant although it was not previously famous, but the team’s research was able to improve the technology and reduce its size in a way that adds more uses and makes it able to target human DNA.
He also pointed out that the technology opens border horizons in medical treatment, which the company hopes to do in the future. Instead of being satisfied with treating genetic diseases such as Alzheimer’s and others, technology can move to a stage beyond that through human genetic modification, adding specific genes to its DNA or even modifying specific genes to get rid of the factors that stimulate heart attacks, for example, or factors that stimulate diseases such as obesity.
Of course, such technologies usually face great legal and legislative challenges, but the presence of these challenges does not negate their existence or undermine their importance. In the end, “Krisper” technology can help eliminate diseases that have always eliminated humans such as cancer, Alzheimer’s and others.